Wellgistics Health Reports First Quarter 2026 Financials and Provides Business Update

May 19, 2026 4:10 PM

Wellgistics Health, Inc. (NASDAQ:WGRX), a health information technology company, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™ with licensed blockchain-enabled smart contract technology through PharmacyChain™, reported financial results for the first quarter ended March 31, 2026 and provided a second quarter 2026 business update from its President & Interim-CEO Prashant Patel, RPh."The...

Read more

Bulletin From Annual General Meeting in Senzime AB (publ)

May 19, 2026 12:20 PM

Senzime (STO:SEZI) (OTCQX:SNZZF) - The annual general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the "Company") was held on 19 May 2026 at the Company's premises on Verkstadsgatan 8, Uppsala, whereby the shareholders primarily resolved on the following matters.Annual report and resultsThe annual general meeting adopted the income statement and the balance sheet for the financial year 2025 and resolved, in accordance with the board...

Read more

DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals

May 19, 2026 12:10 PM

DaVita announced its 2030 Community Care commitments, a new set of long-term goals, focused on improving patient outcomes, supporting the expansion of economic opportunity for teammates, and strengthening community and environmental resilience. The announcement follows the company achieving or exceeding the majority of its prior five-year environmental, social and governance (ESG) goals, reinforcing DaVita's track record of turning ambition into...

Read more

Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering

May 19, 2026 12:05 PM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and developing life‑saving medicines across oncology, antivirals, and other key therapeutic areas, today announced the closing of its previously announced public offering made on a reasonable best efforts basis with gross proceeds to the Company of approximately $6.0 million, before deducting placement agent fees and other offering expenses payable by the...

Read more

New Illinois Hospital Pricing Data Reveal Massive Markups and Wildly Different Charges for the Same Drugs

May 19, 2026 11:20 AM

A new analysis released today by 3 Axis Advisors, drawing on data from Patient Rights Advocates' hospital drug price finder, reveals striking disparities in what Illinois hospitals charge for the same prescription drugs - including critical cancer treatments.The research raises fresh questions about hospital pricing practices as state lawmakers consider legislation to expand the federal 340B drug discount program."These numbers expose a hospital...

Read more

AP Technologies Acquires Blueacre Technology, Adding Nitinol and Precision Laser Processing to Its Catheter Platform

May 19, 2026 10:00 AM

AP Technologies, a vertically integrated contract manufacturer of catheters and medical tubing, today announced the acquisition of Blueacre Technology, a Dundalk, Ireland specialist in laser micromachining and nitinol processing for the medical device industry. The acquisition establishes AP Technologies' first European operation in Ireland's medtech corridor, and extends its catheter platform into the laser-processed metallic components used in...

Read more

AcutePet Urgent Care Expands into Grove City, Bringing Same-Day Pet Care to Columbus Communities

May 19, 2026 9:50 AM

AcutePet Urgent Care is bringing its eighth location to Grove City, providing accessible, same-day veterinary care to pet families throughout south Columbus and surrounding communities. Conveniently located at 3612 Hoover Road near Stringtown Road and just minutes from Grove City Town Center, Target, Kroger, Mount Carmel Grove City, and Grove City High School. AcutePet will open to the public on Friday, May 22 at 10:00 a.m. and will be open...

Read more

Medical Care Technologies (OTC PINK:MDCE) Positions Its Next-Generation AI Strategy Amid Rapid Breakthroughs from NVIDIA and Anthropic

May 19, 2026 9:15 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), an emerging artificial intelligence and imaging technology company, today announced a strategic evaluation of next-generation AI infrastructure and multimodal vision systems following major advancements from industry leaders NVIDIA and Anthropic that may materially accelerate the Company's AI commercialization roadmap. Recent breakthroughs in artificial intelligence have...

Read more

CLS Health's Dr. Barkha Chhabra Helps Child Born with Three Rare Conditions to Walk Normally

May 19, 2026 9:00 AM

Isaac was born with not one but three rare medical conditions - occurring together perhaps one in several million births and making diagnosis and treatment extraordinarily complex. A case study from Dr. Barkha Chhabra, a pediatric orthopedic surgeon with CLS Health, illustrates how a team of dedicated physicians delivered a solution, one cast, one therapy session, and one small step at a time.CLS Health, the physician-owned and physician-led...

Read more

Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA) for Liquid Oral Crofelemer

May 19, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) announced that the first patient from the cohort of pediatric MVID patients in the pivotal MVID randomized double-blind crossover clinical trial has entered the active treatment only single-blind extension to evaluate the longer term safety and efficacy of crofelemer powder for oral solution as adjunctive treatment to parenteral support (PS) to support...

Read more

CVS Health(R) and WGU Launch Online Pre-Pharmacy Degree Program for Future Pharmacists Nationwide

May 19, 2026 9:00 AM

Originally published on CVS Health Company NewsroomCVS Health® (NYSE: CVS) and WGU today announced a new online pre-pharmacy degree program designed to help address the national need for pharmacists through flexible, affordable education. Developed in collaboration with CVS Health, WGU's fully online Associate of Science-Health Science (ASHS), Pre-Pharmacy degree program helps CVS Health colleagues complete foundational academic prerequisites at...

Read more

Europe's Hospital Cybersecurity Hot Zones and Top Cyber Vendors as EHR and EPR Attacks Shift From Data Theft to Care Disruption

May 19, 2026 8:50 AM

Black Book Research today issued a new European hospital cybersecurity advisory identifying the countries, attack surfaces, vendor categories, and evaluation standards now shaping hospital cybersecurity buying decisions across Europe.The advisory builds on Black Book's Pre-HIMSS26 Europe Copenhagen Cybersecurity Demand Pulse Survey of 284 self-identified European hospital, health system, HIT, clinical-digital, cybersecurity, procurement, risk,...

Read more

Empirical Spine Announces First Commercial LimiFlex(R) Cases at Stanford Medicine, Marking U.S. Launch of Motion-Preserving Alternative to Fusion for Degenerative Spondylolisthesis

May 19, 2026 8:30 AM

Empirical Spine announces the U.S. market introduction of the LimiFlex Dynamic Sagittal Tether™, an outpatient, motion-preserving alternative to spinal fusion following decompression. Todd Alamin, MD, Empirical Spine Co-founder, successfully performed the first two commercial implantations of the Class III dynamic stabilization device designed to treat Grade I lumbar degenerative spondylolisthesis with stenosis1, at Stanford Medicine on April...

Read more

Protagenic Therapeutics Engages Floyd Regulatory Strategic Consulting as Regulatory Affairs Advisor and Danforth Health as Strategic Operations Partner

May 19, 2026 8:15 AM

Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company developing novel peptide-based therapies for stress-related neuropsychiatric disorders, today announced two strategic engagements to support the advancement of its lead candidate, PT00114. The Company has engaged Floyd Regulatory Strategic Consulting, led by regulatory affairs veteran Dr. Eric Floyd, Ph.D., MBA, as Regulatory Affairs Advisor, and...

Read more

Black Book Research Releases State of Digital Healthcare IT 2026: Norway Market Report

May 19, 2026 7:47 AM

Black Book Research has released State of Digital Healthcare IT 2026: Norway, a new market intelligence report examining one of Europe's most digitally mature healthcare environments as Norway moves from foundational digitization to the next phase of healthcare IT optimization.Industry stakeholders can download the complimentary report at:https://blackbookmarketresearch.com/state-of-digital-healthcare-it-norway-2026The report provides a...

Read more

Contract Complexity Is Costing You: 5 Ways to Spot Underpayments

May 19, 2026 7:00 AM

In today's healthcare environment, hospitals and health systems are under increasing pressure to protect margins while navigating complex payer contracts. Unfortunately, many organizations are leaving significant revenue on the table due to contract complexity, inadequate contract analysis, and overlooked underpayments.For hospital executives, this is more than an operational issue - it's a bottom-line risk. Without the right contract management...

Read more

AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain

May 19, 2026 4:20 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that it will host a live seminar on 26 May from 14:00 to 15:00 CEST focusing on ACD137, the leading drug candidate in the TrkA-NAM pain project.The company recently published new results* for the TrkA-NAM pain project ACD137, and the purpose of the...

Read more

Spago Nanomedical Publishes the Annual Report for 2025

May 19, 2026 3:15 AM

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)Spago Nanomedical's annual report for 2025 is from today available at the company's website, https://spagonanomedical.se/investor-relations/#financial-reportsFor further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, [email protected] Nanomedical AB is a Swedish company in clinical development phase. The company´s development projects are based on a...

Read more

BioNxt Advances Semaglutide ODF Program into Active Pharmaceutical Development

May 19, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that its Semaglutide oral dissolvable film ("ODF") program has entered the active pharmaceutical development phase in collaboration with German drug development partner Gen-Plus GmbH.The advancement represents a significant strategic milestone for BioNxt as the Company...

Read more

Cantargia Publishes Interim Report for The First Quarter of 2026

May 19, 2026 1:25 AM

Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced its interim report for the first quarter of 2026."The first quarter of 2026 reflects both strong execution and important strategic progress for Cantargia. We have delivered promising early clinical data in MDS, advanced our pipeline, and taken decisive steps to position the Company for increased long-term value creation in a rapidly evolving treatment landscape.", said Hilde Steineger,...

Read more